Purchase this article with an account.
J. Chae, K. Cho, J. Lee, J.-G. Kim, J. Koh, Y. Yoon; Inhibitory Effect of Choroidal Neovascularization in Rat by Systemic Administration of Protein Kinase C Inhibitor, Benzthiazole Derivatives. Invest. Ophthalmol. Vis. Sci. 2009;50(13):789.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To investigate the inhibitory effect of intraperitoneally administered Benzthiazole derivative, Protein Kinase C inhibitor, in laser induced choroidal neovascularization of rat.
In 36 eyes of 36 Female Brown Norway Rats, CNV was induced by Argon laser photocoagulation at the onset of experiment. They are divided into three groups: 10mg/kg Benzthiazole derivative with DMSO injection group, only DMSO injection group, and no treatment group (control). After 14 days, Fluorescein angiography (FA) was performed, and the amount of fluorescein leakage was assessed by Clinical score. All the eyes were enucleated at the next day after FA, and the thickness of choroidal neovascularization was measured by Hematoxylin and Eosin Stain. Also, VEGF (vascular endothelial growth factor), and PDGF (platelet derived growth factor) were assessed immunohistochemically.
In Benzthiazole derivate injection group, Choroidal neovascularization was significantly reduced on clinical score of FA (P-value<0.05). The CNV thickness of Benzthiazole derivative treatment group was thinner than Control group (pure DMSO injection group, and no treatment group) on Hematoxylin and Eosin stain. On immunohistochemistry stain, VEGF and PDGF were less expressed at Benzthiazole derivative treatment group.
Benzthizole derivative can reduce the laser induced choroidal neovascularization of rat, and may be useful in treatment of CNV.
This PDF is available to Subscribers Only